Showing results (161-170 of 463) with videos related to

Sort By:
Pageof 47
Critical Care (London, England)|May 1, 2015
Impact of ICU-acquired weakness on post-ICU physical functioning: a follow-up studyLuuk Wieske, Daniela S Dettling-Ihnenfeldt, Camiel Verhamme, et al.
Pharmacogenetics and Genomics|September 28, 2011
Novel CYP3A4 intron 6 single nucleotide polymorphism is associated with simvastatin-mediated cholesterol reduction in the Rotterdam StudyLaure Elens, Matthijs L Becker, Vincent Haufroid, et al.
Drug Metabolism and Personalized Therapy|October 3, 2014
No effect of CYP3A4 intron 6 C>T polymorphism (CYP3A4*22) on lipid-lowering response to statins in Greek patients with primary hypercholesterolemiaGeorgia Ragia, Vana Kolovou, Anna Tavridou, et al.
European Journal of Neurology|April 5, 2021
Borrelia burgdorferi sensu lato seroconversion after intravenous immunoglobulin treatment: A cohort studyIlse M Lucke, Amber Vrijlandt, Johan Lim, et al.
Genomics|July 3, 2003
Transcriptional profile of the human peripheral nervous system by serial analysis of gene expressionRosalein R de Jonge, Jeroen P Vreijling, Asker Meintjes, et al.
The Journal of Antimicrobial Chemotherapy|September 11, 2007
Hepatotoxicity of oral and intravenous voriconazole in relation to cytochrome P450 polymorphismsMark-David Levin, Jan G den Hollander, Bronno van der Holt, et al.
European Journal of Neurology|May 7, 2010
Age-related changes in motor unit number estimates in adult patients with Charcot-Marie-Tooth type 1AJ P van Dijk, C Verhamme, I N van Schaik, et al.
Leukemia Research|May 27, 2009
Polymorphisms in genes involved in vincristine pharmacokinetics or pharmacodynamics are not related to impaired motor performance in children with leukemiaA Hartman, R H N van Schaik, I P van der Heiden, et al.
The Pharmacogenomics Journal|December 22, 2011
Genetic variation in the ABCC2 gene is associated with dose decreases or switches to other cholesterol-lowering drugs during simvastatin and atorvastatin therapyM L Becker, L L F S Elens, L E Visser, et al.
Therapeutic Drug Monitoring|February 23, 2012
Associations between ABCB1, CYP2A6, CYP2B6, CYP2D6, and CYP3A5 alleles in relation to efavirenz and nevirapine pharmacokinetics in HIV-infected individualsSandra G Heil, Marchina E van der Ende, Paul W Schenk, et al.
Pageof 47